Target
Complement factor D
Ligand
BDBM511713
Substrate
n/a
Meas. Tech.
Factor D Assay
IC50
<1000±n/a nM
Citation
 Wiles, JAPhadke, ASDeshpande, MAgarwal, AChen, DGadhachanda, VRHashimoto, APais, GWang, QWang, XBarrish, JCGreenlee, WEastman, KJ Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders US Patent  US11084800 Publication Date 8/10/2021 
Target
Name:
Complement factor D
Synonyms:
Adipsin | C3 convertase activator | CFAD_HUMAN | CFD | DF | PFD | Properdin factor D
Type:
Protein
Mol. Mass.:
27039.19
Organism:
Homo sapiens (Human)
Description:
P00746
Residue:
253
Sequence:
MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA
  
Inhibitor
Name:
BDBM511713
Synonyms:
(1R,3S,5R)-2-(2-(3-acetyl-7-methyl-5-(2- methylpyrimidin-5-yl)-1H-indazol-1- yl)acetyl)-N-(6-bromopyridin-2-yl)-5-methyl- 2-azabicyclo[3.1.0]hexane-3-carboxamide | US11084800, Cpd No. 18 | US11708351, Compound 336
Type:
Small organic molecule
Emp. Form.:
C29H28BrN7O3
Mol. Mass.:
602.482
SMILES:
CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]3(C)C[C@H]2C(=O)Nc2cccc(Br)n2)c2c(C)cc(cc12)-c1cnc(C)nc1 |r|
Structure:
Search PDB for entries with ligand similarity: